LATRICIA RILEY: Open Payments
NPI 1659735645 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,969 in 77 payments from 19 companies in 2025. Trend: 2023 $480 · 2024 $1,116 · 2025 $1,969
Food & beverage: $1,910Education: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $512 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $224 |
| Regeneron Healthcare Solutions, Inc. | 6 | $185 |
| Lilly USA, LLC | 3 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $151 |
| Axsome Therapeutics, Inc. | 1 | $113 |
| Pharming Healthcare, Inc. | 4 | $100 |
| CSL Behring | 4 | $94 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| Cycle Pharmaceuticals Inc | 3 | $73 |
Products named: BREZTRI, DUPIXENT, EBGLYSS, TEZSPIRE, Auvelity, CUVITRU, RUCONEST, HYQVIA.
Industry payments across KY — which companies pay providers there.
